yea I saw the list of interested vendors already. But does you name have to be on this list for you to take part? I wasnt sure about that part. Does anybody know if you can not have your name on the list and still send in a draft proposal?
That's why i was wondering if, by tomorrow, we would be be able to know who exactly sent in a proposal, regardless of whether they are on the list or not (since NG isnt on the list of interested vendors at the moment)
@Quiver
yea ive seen those claims regarding dragonfly. It says that it can test for 6 organisms at once, right? The thing about xMAP is that I think it can easily test for 100+ organisms at once...at least theoretically, which is why I think it has a bright future (and hence why it got the fundng for a prototype device). Dragonfly still is viable though of course, especially at the present. I'm sure the system can be expanded to include more biothreats if necessary (will be much harder to reach 100 tests with current multiplexing systems though). It probably is signifcantly cheaper at the moment as well. I was just trying to point out that xMAP probably has a very bright future in certain, more clinically-oriented, fields
Regarding TaqMan PCR - TaqMan is nothing more than the probes used at the end of the qPCR (it is a good thing though - TaqMan is very reliable). The actual method being used is real-time PCR (aka qPCR). it seems that our system is holding up well to the DHS standards. The question is how will it hold up to possible competitor. This is why I am very anxious about what NG will bring to the table, if anything at all. As long as they are in the running, I cant sit easy and think we have an easy victory.
AI
